Long COVID and Unemployment in Hawaii.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
27 06 2023
Historique:
received: 16 04 2023
revised: 20 06 2023
accepted: 24 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

The state of Hawaii has seen 390,000 COVID-19 cases and nearly 1900 deaths since the start of the pandemic. Although the negative impact of the pandemic on employment has been widely documented, this paper demonstrates that those who were infected and suffer from lingering symptoms (i.e., long COVID) had different employment outcomes than those who did not experience such symptoms. Using data from our longitudinal cohort in the state of Hawaii, we found that those who reported long COVID in May 2022 were 6.43% more likely to be unemployed at the time of the May survey and 7.07% more likely in November 2022. In addition, we showed that vaccination is associated with higher rates of employment; each additional vaccine an individual received by May decreased the likelihood of unemployment by 6.9% in May and 3.9% in November. Further, individuals who reported more severe symptoms of long COVID were 6.36% less likely to be employed in May and 5.75% less likely to be employed in November. Our results suggest that vaccination policies and policies aimed at preventing contraction and accommodating individuals with long COVID may be effective measures for mitigating the adverse effects of the pandemic on employment.

Identifiants

pubmed: 37444079
pii: ijerph20136231
doi: 10.3390/ijerph20136231
pmc: PMC10341770
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : OT2 HD108105
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007601
Pays : United States

Références

BMC Public Health. 2021 May 31;21(1):1023
pubmed: 34059034
Vaccines (Basel). 2022 May 13;10(5):
pubmed: 35632529
J R Soc Med. 2021 Sep;114(9):428-442
pubmed: 34265229
Vaccines (Basel). 2023 Mar 21;11(3):
pubmed: 36992290
Clinicoecon Outcomes Res. 2022 Apr 28;14:293-307
pubmed: 35509962
Vaccines (Basel). 2022 Jun 18;10(6):
pubmed: 35746581
Am J Public Health. 2022 Nov;112(S9):S896-S899
pubmed: 36108254
Vaccines (Basel). 2022 Aug 31;10(9):
pubmed: 36146513
Econ Disaster Clim Chang. 2022;6(2):339-353
pubmed: 35434497
Vaccines (Basel). 2022 Jun 17;10(6):
pubmed: 35746577

Auteurs

Carl Bonham (C)

Department of Economics and UHERO, University of Hawaii, 2424 Maile Way, Saunders 542, Honolulu, HI 96822, USA.

Ruben Juarez (R)

Department of Economics and UHERO, University of Hawaii, 2424 Maile Way, Saunders 542, Honolulu, HI 96822, USA.

Nicole Siegal (N)

Department of Economics and UHERO, University of Hawaii, 2424 Maile Way, Saunders 542, Honolulu, HI 96822, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH